ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

JBDI vs SXTC // EV/EBITDA & P/E VALUATION

JBDI Holdings Limited (NASDAQ) VS. China SXT Pharmaceuticals Inc. (NASDAQ) • 15-METRIC TALLY: JBDI 6 — SXTC 0
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (JBDI VS. SXTC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC JBDI SXTC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 49.90% 21.90% +28.00 JBDI /gross-margins <GO>
Return on Invested Capital (ROIC) — — — TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield -2.01% — — TIE /fcf-yield <GO>
Operating Margin -2.00% -60.00% +58.00 JBDI /operating-margins <GO>
Net Profit Margin 1.40% -60.00% +61.40 JBDI /net-margins <GO>
Revenue Growth (YoY) 0.90% — — TIE /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 JBDI /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 60.6 27.7 +32.86 JBDI /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $22.9M $367.7K $22.6M JBDI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR JBDI REV SXTC REV JBDI GROSS % SXTC GROSS % JBDI FCF SXTC FCF
FY 2025 $8.5M $1.1M 49.9% 21.9% -$462.0K -$4.0M
FY 2024 $8.4M $1.7M 39.7% 21.1% -$3.4M -$2.3M
FY 2023 $9.4M $1.9M — — $1.0M -$1.9M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
JBDI // BETA —
SXTC // BETA —